In another similar study, expression of miR-30c has been linked to chemotherapy resistance specifically in luminal A breast tumours by regulating TWF1 and IL-11 genes in the miR-30c-mediated pathway (Bockhorn et al., 2013) and deregulation of miR-30c has led to increase in cell proliferation, drug sensitivity and cancer progression. This evidence concerns the gene IL11 and breast neoplasm.